Camford Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Camford Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Dec 1, 2023	Totus Medicines	$66.0M Series B	John Hamer	Zachary Bogue, DCVC (Data Collective), Dimension Capital, Pivotal bioVenture Partners, The Column Group, Northpond Ventures, University of Minnesota
Oct 1, 2023	Engine Biosciences	$27.0M Series A	Amy Schulman	HealthQuest Capital, Koch Fund, Lightspeed Venture Partners, Polaris Partners, Ali Farahanchi, Wen Qi Ho, EDBI, Invus, SEEDS Capital
Jul 19, 2023	FEDML	$11.5M Seed	Ali Farahanchi	Adam Winnick, Thomas Bailey
Jul 1, 2023	SURGE Therapeutics	$32.0M Series B	Bioluminescence Ventures	5AM Ventures, Arix Bioscience, F-Prime Capital Partners, Intuitive Ventures, 8VC, Alumni Ventures, Cancer Research Institute, KdT Ventures, Khosla Ventures, Piedmont Capital, Pitango HealthTech
May 10, 2023	Lavita	$5.0M Seed	Camford Capital	—
Dec 8, 2022	Vevo Therapeutics	$12.0M Seed	Deep Nishar, Gaurav Garg	AIX Ventures, Ayman AlAbdallah
Oct 1, 2022	SURGE Therapeutics	$26.0M Series A	Camford Capital	Bioluminescence Ventures, Intuitive Ventures, 8VC, Alumni Ventures, Cancer Research Institute, Khosla Ventures, Pitango HealthTech
Jun 1, 2022	Carbon Biosciences	$38.0M Series A	Agent Capital	Hiromichi Kimura, Astellas Venture Management, Martin Mense, David Steinberg, Derek Yoon, University of Tokyo Edge Capital
Jun 1, 2021	Strand Therapeutics	$52.0M Series A	—	FPV Fund, Kinnevik, Playground Global, ANRI, BeiGene, Redmile Group
Dec 10, 2020	CG Oncology	$47.0M Series D	Mutsuo Kanzawa	ORI Healthcare Fund, Perseverance Capital Management